Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Drugs & Aging
Erschienen in: Drugs & Aging 3/2005

01.03.2005 | Review Article

Assessing Medication Adherence in the Elderly

Which Tools to Use in Clinical Practice?

verfasst von: Eric J. MacLaughlin, Professor Cynthia L. Raehl, Angela K. Treadway, Teresa L. Sterling, Dennis P. Zoller, Chester A. Bond

Erschienen in: Drugs & Aging | Ausgabe 3/2005

Einloggen, um Zugang zu erhalten

Abstract

Adherence to prescribed medication regimens is difficult for all patients and particularly challenging for the elderly. Medication adherence demands a working relationship between a patient or caregiver and prescriber that values open, honest discussion about medications, i.e. the administration schedule, intended benefits, adverse effects and costs.
Although nonadherence to medications may be common among the elderly, fundamental reasons leading to nonadherence vary among patients. Demographic characteristics may help to identify elderly patients who are at risk for nonadherence. Inadequate or marginal health literacy among the elderly is common and warrants assessment. The number of co-morbid conditions and presence of cognitive, vision and/or hearing impairment may predispose the elderly to nonadherence. Similarly, medications themselves may contribute to nonadherence secondary to adverse effects or costs. Especially worrisome is nonadherence to ‘less forgiving’ drugs that, when missed, may lead to an adverse event (e.g. withdrawal symptoms) or disease exacerbation.
Traditional methods for assessing medication adherence are unreliable. Direct questioning at the patient interview may not provide accurate assessments, especially if closed-ended, judgmental questions are posed. Prescription refill records and pill counts often overestimate true adherence rates. However, if elders are asked to describe how they take their medicines (using the Drug Regimen Unassisted Grading Scale or MedTake test tools), adherence problems can be identified in a nonthreatening manner.
Medication nonadherence should be suspected in elders who experience a decline in functional abilities. Predictors of medication nonadherence include specific disease states, such as cardiovascular diseases and depression. Technological aids to assessing medication adherence are available, but their utility is, thus far, primarily limited to a few research studies. These computerised devices, which assess adherence to oral and inhaled medications, may offer insight into difficult medication management problems. The most practical method of medication adherence assessment for most elderly patients may be through patient or caregiver interview using open-ended, nonthreatening and nonjudgmental questions.
Fußnoten
1
The use of trade names is for product identification purposes only and does not imply endorsement.
 
Literatur
1.
Haynes RB, McDonald H, Garg AX, et al. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev 2002; (2): CD000011
2.
McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA 2002; 288: 2868–79PubMedCrossRef
3.
Roter DL, Hall JA, Merisca R, et al. Effectiveness of interventions to improve patient compliance: a meta analysis. Med Care 1998; 36: 1138–61PubMedCrossRef
4.
van Eijken M, Tsang S, Wensing M, et al. Interventions to improve medication compliance in older patients living in the community: a systematic review of the literature. Drugs Aging 2003; 20: 229–40PubMedCrossRef
5.
Urquhart J, Chevalley C. Impact of unrecognized dosing errors on the cost and effectiveness of pharmaceuticals. Drug Inf J 1988; 22: 363–78
6.
Peterson AM, Takiya L, Finley R. Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm 2003; 60: 657–65PubMed
7.
8.
Urquhart J. Role of patient compliance in clinical pharmacokinetics: a review of recent research. Clin Pharmacokinet 1994; 27: 202–15PubMedCrossRef
9.
Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990; 150: 841–5PubMedCrossRef
10.
Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J 2001; 31: 199–205PubMedCrossRef
11.
Morrow D, Leirer V, Sheikh J. Adherence and medication instructions: review and recommendations. J Am Geriatr Soc 1988; 36: 1147–60PubMed
12.
Gray SL, Mahoney JE, Blough DK. Medication adherence in elderly patients receiving home health services following hospital discharge. Ann Pharmacother 2001; 35: 539–45PubMedCrossRef
13.
Cramer JA. Microelectronic systems for monitoring and enhancing patient compliance with medication regimens. Drugs 1995; 49: 321–7PubMedCrossRef
14.
Balkrishnan R. Predictors of medication adherence in the elderly. Clin Ther 1998; 20: 764–71PubMedCrossRef
15.
Cooper JK, Love DW, Raffoul PR. Intentional prescription nonadherence (noncompliance) by the elderly. J Am Geriatr Soc 1982; 30: 329–33PubMed
16.
Coons SJ, Sheahan SL, Martin SS, et al. Predictors of medication noncompliance in a sample of older adults. Clin Ther 1994; 16: 110–7PubMed
17.
Monane M, Bohn RL, Gurwitz JH, et al. Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race. Am J Public Health 1996; 86: 1805–8PubMedCrossRef
18.
Billups SJ, Malone DC, Carter BL. The relationship between drug therapy noncompliance and patient characteristics, health-related quality of life, and health care costs. Pharmacotherapy 2000; 20: 941–9PubMedCrossRef
19.
Park DC, Morrell RW, Frieske D, et al. Medication adherence behaviors in older adults: effects of external cognitive supports. Psychol Aging 1992; 7: 252–6PubMedCrossRef
20.
21.
Baker DW, Gazmararian JA, Sudano J, et al. The association between age and health literacy among elderly persons. J Gerontol B Psychol Sci Soc Sci 2000; 55: S368–74PubMedCrossRef
22.
Gazmararian JA, Baker DW, Williams MV, et al. Health literacy among Medicare enrollees in a managed care organization. JAMA 1999; 281: 545–51PubMedCrossRef
23.
Scott TL, Gazmararian JA, Williams MV, et al. Health literacy and preventive health care use among Medicare enrollees in a managed care organization. Med Care 2002; 40: 395–404PubMedCrossRef
24.
Health literacy: report of the Council on Scientific Affairs. Ad Hoc Committee on Health Literacy for the Council on Scientific Affairs, American Medical Association. JAMA 1999; 281: 552–7
25.
Baker DW, Williams MV, Parker RM, et al. Development of a brief test to measure functional health literacy. Patient Educ Couns 1999; 38: 33–42PubMedCrossRef
26.
Ruscin JM, Semla TP. Assessment of medication management skills in older outpatients. Ann Pharmacother 1996; 30: 1083–8PubMed
27.
DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160: 2101–7PubMedCrossRef
28.
Raehl CL, Bond CA, Woods T, et al. Individualized drug use assessment in the elderly. Pharmacotherapy 2002; 22: 1239–48PubMedCrossRef
29.
Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001; 23: 1296–310PubMedCrossRef
30.
Christensen DB, Williams B, Goldberg HI, et al. Assessing compliance to antihypertensive medications using computerbased pharmacy records. Med Care 1997; 35: 1164–70PubMedCrossRef
31.
Eisen SA, Miller DK, Woodward RS, et al. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 1990; 150: 1881–4PubMedCrossRef
32.
Cramer J, Vachon L, Desforges C, et al. Dose frequency and dose interval compliance with multiple antiepileptic medications during a controlled clinical trial. Epilepsia 1995; 36: 1111–7PubMedCrossRef
33.
Cramer JA, Mattson RH, Prevey ML, et al. How often is medication taken as prescribed? A novel assessment technique. JAMA 1989; 261: 3273–7PubMedCrossRef
34.
Taggart AJ, Johnston GD, McDevitt DG. Does the frequency of daily dosage influence compliance with digoxin therapy? Br J Clin Pharmacol 1981; 11: 31–4PubMedCrossRef
35.
Kruse W, Eggert-Kruse W, Rampmaier J, et al. Dosage frequency and drug-compliance behaviour: a comparative study on compliance with a medication to be taken twice or four times daily. Eur J Clin Pharmacol 1991; 41: 589–92PubMedCrossRef
36.
Tinkelman DG, Vanderpool GE, Carroll MS, et al. Compliance differences following administration of theophylline at six- and twelve-hour intervals. Ann Allergy 1980; 44: 283–6PubMed
37.
Pullar T, Birtwell AJ, Wiles PG, et al. Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily. Clin Pharmacol Ther 1988; 44: 540–5PubMedCrossRef
38.
Pushpangadan M, Feely M. Once a day is best: evidence or assumption? The relationship between compliance and dosage frequency in older people. Drugs Aging 1998; 13: 223–7PubMedCrossRef
39.
Greenberg RN. Overview of patient compliance with medication dosing: a literature review. Clin Ther 1984; 6: 593–9
40.
Boissel JP, Nony P. Using pharmacokinetic-pharmacodynamic relationships to predict the effect of poor compliance. Clin Pharmacokinet 2002; 41: 1–6PubMedCrossRef
41.
Rudd P, Lenert L. Pharmacokinetics as an aid to optimising compliance with medications. Clin Pharmacokinet 1995; 28: 1–6PubMedCrossRef
42.
Burris JF, Papademetriou V, Wallin JD, et al. Therapeutic adherence in the elderly: transdermal clonidine compared to oral verapamil for hypertension. Am J Med 1991; 91: 22S–8SPubMedCrossRef
43.
de Klerk E. Patient compliance with enteric-coated weekly fluoxetine during continuation treatment of major depressive disorder. J Clin Psychiatry 2001; 62: 43–7PubMed
44.
45.
Sharkness CM, Snow DA. The patient’s view of hypertension and compliance. Am J Prev Med 1992; 8: 141–6PubMed
46.
Lakshman M, Fernando M, Kazarian SS. Patient education in the drug treatment of psychiatric disorders. CNS Drugs 1995; 3: 291–304CrossRef
47.
Stewart RB, Caranasos GJ. Medication compliance in the elderly. Med Clin North Am 1989; 73: 1551–63PubMed
48.
Lin IF, Spiga R, Fortsch W. Insight and adherence to medication in chronic schizophrenics. J Clin Psychiatry 1979; 40: 430–2PubMed
49.
Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002; 288: 462–7PubMedCrossRef
50.
Meredith PA. Therapeutic implications of drug ‘holidays’. Eur Heart J 1996; 17Suppl. A: 21–4PubMedCrossRef
51.
52.
Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med 1990; 150: 1509–10PubMedCrossRef
53.
Feinstein AR. On white-coat effects and the electronic monitoring of compliance. Arch Intern Med 1990; 150: 1377–8PubMedCrossRef
54.
Garfield FB, Caro JJ. Achieving patient buy-in and long term compliance with antihypertensive treatment. Dis Manage Health Outcomes 2000; 7: 13–20CrossRef
55.
Willey C, Redding C, Stafford J, et al. Stages of change for adherence with medication regimens for chronic disease: development and validation of a measure. Clin Ther 2000; 22: 858–71PubMedCrossRef
56.
Edelberg HK, Shallenberger E, Wei JY. Medication management capacity in highly functioning community-living older adults: detection of early deficits. Am Geriatr Soc 1999; 47: 592–6
57.
Pullar T, Kumar S, Tindall H, et al. Time to stop counting the tablets? Clin Pharmacol Ther 1989; 46: 163–8PubMedCrossRef
58.
Rudd P, Byyny RL, Zachary V, et al. The natural history of medication compliance in a drug trial: limitations of pill counts. Clin Pharmacol Ther 1989; 46: 169–76PubMedCrossRef
59.
Paes AH, Bakker A, Soe-Agnie CJ. Measurement of patient compliance. Pharm World Sci 1998; 20: 73–7PubMedCrossRef
60.
Mojtabai R, Olfson M. Medication costs, adherence, and health outcomes among medicare beneficiaries. Health Affairs 2003; 22: 220–9PubMedCrossRef
61.
Paris W, Dunham S, Sebastian A, et al. Medication nonadherence and its relation to financial restriction. J Transpl Coord 1999; 9: 149–52PubMed
62.
Schoen MD, DiDomenico RJ, Connor SE, et al. Impact of the cost of prescription drugs on clinical outcomes in indigent patients with heart disease. Pharmacotherapy 2001; 21: 1455–63PubMedCrossRef
63.
Secnik K, Pathak DS, Cohen JM. Postcard and telephone reminders for unclaimed prescriptions: a comparative evaluation using survival analysis. J Am Pharm Assoc (Wash) 2000; 40: 243–51
64.
Meyer ME, Schuna AA. Assessment of geriatric patients’ functional ability to take medication. DICP 1989; 23: 171–4PubMed
65.
Fitten LJ, Coleman L, Siembieda DW, et al. Assessment of capacity to comply with medication regimens in older patients. J Am Geriatr Soc 1995; 43: 361–7PubMed
66.
Edelberg HK, Shallenberger E, Wei JY. One-year follow-up of medication management capacity in highly functioning older adults. J Gerontol A Biol Sci Med Sci 2000; 55: M550–3PubMedCrossRef
67.
Hurd PD, Blevins J. Aging and the color of pills [letter]. N Engl J Med 1984; 310: 202PubMed
68.
Hurd PD, Butkovich SL. Compliance problems and the older patient: assessing functional limitations. Drug Intell Clin Pharm 1986; 20: 228–31PubMed
69.
Keram S, Williams ME. Quantifying the ease or difficulty older persons experience in opening medication containers. J Am Geriatr Soc 1988; 36: 198–201PubMed
70.
Morrell RW, Park DC, Poon LW. Quality of instructions on prescription drug labels: effects on memory and comprehension in young and old adults. Gerontologist 1989; 29: 345–54PubMedCrossRef
71.
Murray MD, Darnell J, Weinberger M, et al. Factors contributing to medication noncompliance in elderly public housing tenants. Drug Intell Clin Pharm 1986; 20: 146–52PubMed
72.
Morrell RW, Park DC, Poon LW. Effects of labeling techniques on memory and comprehension of prescription information in young and old adults. J Gerontol 1990; 45: P166–72PubMedCrossRef
73.
Hanchak NA, Patel MB, Berlin JA, et al. Patient misunderstanding of dosing instructions. J Gen Intern Med 1996; 11: 325–8PubMedCrossRef
74.
Isaac LM, Tamblyn RM. Compliance and cognitive function: a methodological approach to measuring unintentional errors in medication compliance in the elderly. McGill-Calgary Drug Research Team. Gerontologist 1993; 33: 772–81PubMedCrossRef
75.
Turner J, Wright E, Mendella L, et al. Predictors of patient adherence to long-term home nebulizer therapy for COPD. The IPPB Study Group. Intermittent Positive Pressure Breathing. Chest 1995; 108: 394–400PubMedCrossRef
76.
Gray SL, Williams DM, Pulliam CC, et al. Characteristics predicting incorrect metered-dose inhaler technique in older subjects. Arch Intern Med 1996; 156: 984–8PubMedCrossRef
77.
Partridge AH, Wang PS, Winer EP, et al. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol 2003; 21: 602–6PubMedCrossRef
78.
Roe CM, Motheral BR, Teitelbaum F, et al. Compliance with and dosing of angiotensin-converting-enzyme inhibitors before and after hospitalization. Am J Health Syst Pharm 2000; 57: 139–45PubMed
79.
Camus V, Kraehenbuhl H, Preisig M, et al. Geriatric depression and vascular diseases: what are the links? J Affect Disord 2004; 81(1): 1–16.PubMedCrossRef
80.
Wang PS, Bohn RL, Knight E, et al. Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med 2002; 17: 504–11PubMedCrossRef
81.
Ziegelstein RC, Bush DE, Fauerbach JA. Depression, adherence behavior, and coronary disease outcomes. Arch Intern Med 1998; 158: 808–9PubMedCrossRef
82.
Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 2000; 160: 3278–85PubMedCrossRef
83.
Gurwitz JH, Yeomans SM, Glynn RJ, et al. Patient noncompliance in the managed care setting: the case of medical therapy for glaucoma. Med Care 1998; 36: 357–69PubMedCrossRef
84.
85.
Winfield AJ, Jessiman D, Williams A, et al. A study of the causes of non-compliance by patients prescribed eyedrops. Br J Ophthalmol 1990; 74: 477–80PubMedCrossRef
86.
Averns H, Hall J, Webley M. Role of opticare eye drop delivery system in patients with rheumatoid arthritis. J Rheumatol 1999; 26: 2615–8PubMed
87.
88.
89.
90.
91.
92.
93.
94.
Girvin B, Johnston GD. The implications of noncompliance with antihypertensive medication. Drugs 1996; 52: 186–95PubMedCrossRef
95.
Struthers AD, MacFadyen R, Fraser C, et al. Nonadherence with angiotensin-converting enzyme inhibitor therapy: a comparison of different ways of measuring it in patients with chronic heart failure. J Am Coll Cardiol 1999; 34: 2072–7PubMedCrossRef
96.
97.
98.
99.
100.
101.
102.
103.
104.
105.
106.
107.
108.
Guthrie RM. The effects of postal and telephone reminders on compliance with pravastatin therapy in a national registry: results of the first myocardial infarction risk reduction program. Clin Ther 2001; 23: 970–80PubMedCrossRef
109.
Simkins CV, Wenzloff NJ. Evaluation of a computerized reminder system in the enhancement of patient medication refill compliance. Drug Intell Clin Pharm 1986; 20: 799–802PubMed
110.
Tavitian SM, Kidder PA, Shane R. Contacting patients with unclaimed prescriptions: the pharmacist’s impact on drug therapy concordance. Hosp Pharm 2001; 36: 1060–5
111.
Ascione FJ, Brown GH, Kirking DM. Evaluation of a medication refill reminder system for a community pharmacy. Patient Educ Couns 1985; 7: 157–65PubMedCrossRef
112.
Bishop SK, Winckler SC. Implementing HIPAA privacy regulations in pharmacy practice. J Am Pharm Assoc (Wash) 2002; 42: 836–44
113.
114.
115.
Choo PW, Rand CS, Inui TS, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 1999; 37: 846–57PubMedCrossRef
116.
Averbuch M, Weintraub M, Pollock DJ. Compliance assessment in clinical trials: the MEMS device. J Clin Res Pharmacoepidemiol 1990; 4: 199–204
117.
Waterhouse DM, Calzone KA, Mele C, et al. Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring. J Clin Oncol 1993; 11: 1189–97PubMed
118.
Burney KD, Krishnan K, Ruffin MT, et al. Adherence to single daily dose of aspirin in a chemoprevention trial: an evaluation of self-report and microelectronic monitoring. Arch Fam Med 1996; 5: 297–300PubMedCrossRef
119.
Straka RJ, Fish JT, Benson SR, et al. Patient self-reporting of compliance does not correspond with electronic monitoring: an evaluation using isosorbide dinitrate as a model drug. Pharmacotherapy 1997; 17: 126–32PubMed
120.
Kruse W, Weber E. Dynamics of drug regimen compliance: its assessment by microprocessor-based monitoring. Eur J Clin Pharmacol 1990; 38: 561–5PubMedCrossRef
121.
Matsuyama JR, Mason BJ, Jue SG. Pharmacists’ interventions using an electronic medication-event monitoring device’s adherence data versus pill counts. Ann Pharmacother 1993; 27: 851–5PubMed
122.
Wendel CS, Mohler MJ, Kroesen K, et al. Barriers to use of electronic adherence monitoring in an HIV clinic. Ann Pharmacother 2001; 35: 1010–5PubMedCrossRef
123.
Nides MA, Tashkin DP, Simmons MS, et al. Improving inhaler adherence in a clinical trial through the use of the nebulizer chronolog. Chest 1993; 104: 501–7PubMedCrossRef
124.
Julius SM, Sherman JM, Hendeles L. Accuracy of three electronic monitors for metered-dose inhalers. Chest 2002; 121: 871–6PubMedCrossRef
125.
Simmons MS, Nides MA, Rand CS, et al. Trends in compliance with bronchodilator inhaler use between follow-up visits in a clinical trial. Chest 1996; 109: 963–8PubMedCrossRef
126.
Winland-Brown JE, Valiante J. Effectiveness of different medication management approaches on elders’ medication adherence. Outcomes Manag Nurs Pract 2000; 4: 172–6PubMed
127.
Cherry JC, Moffatt TP, Rodriguez C, et al. Diabetes disease management program for an indigent population empowered by telemedicine technology. Diabetes Technol Ther 2002; 4: 783–91PubMedCrossRef
Metadaten
Titel
Assessing Medication Adherence in the Elderly
Which Tools to Use in Clinical Practice?
verfasst von
Eric J. MacLaughlin
Professor Cynthia L. Raehl
Angela K. Treadway
Teresa L. Sterling
Dennis P. Zoller
Chester A. Bond
Publikationsdatum
01.03.2005
Verlag
Springer International Publishing
Erschienen in
Drugs & Aging / Ausgabe 3/2005
Print ISSN: 1170-229X
Elektronische ISSN: 1179-1969
DOI
https://doi.org/10.2165/00002512-200522030-00005

Weitere Artikel der Ausgabe 3/2005

Drugs & Aging 3/2005 Zur Ausgabe

Current Opinion

Cyclo-Oxygenase-2 Inhibitors

Therapy In Practice

Management of Diabetes Mellitus Medications in the Nursing Home

Original Research Article

Atypical Antipsychotics for Nursing Home Patients

Review Article

Merkel Cell Carcinoma of Skin

Original Research Article

Cytochrome P450 Polymorphisms in Geriatric Patients

Therapy In Practice

Chronic Actinic Dermatitis in the Elderly

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise